Authors:
MARTORELL L
MONCKTON DG
GAMEZ J
JOHNSON KJ
GICH I
DEMUNAIN AL
BAIGET M
Citation: L. Martorell et al., PROGRESSION OF SOMATIC CTG REPEAT LENGTH HETEROGENEITY IN THE BLOOD-CELLS OF MYOTONIC-DYSTROPHY PATIENTS, Human molecular genetics, 7(2), 1998, pp. 307-312
Authors:
GISPERT J
ANTONIJOAN R
BARBANOJ M
GICH I
MORTE A
GARCIA E
ESBRI R
LURIA X
Citation: J. Gispert et al., PHARMACODYNAMIC ASSESSMENT OF THE EFFICACY OF SINGLE AND MULTIPLE DOSES OF EBASTINE, CETIRIZINE AND LORATADINE AGAINST HISTAMINE-INDUCED CUTANEOUS CHALLENGE IN HEALTHY-VOLUNTEERS, Journal of allergy and clinical immunology, 101(1), 1998, pp. 920-920
Citation: L. Falkon et al., IN-VITRO AND EX-VIVO NEUTRALIZING EFFECT OF PROTAMINE SULFATE ON THE ANTICOAGULANT ACTIVITY OF A NEW LOW-MOLECULAR-MASS HEPARIN, Thrombosis research, 89(2), 1998, pp. 79-83
Authors:
ARROYO C
LOPEZCALULL C
GARCIACAPDEVILA L
GICH I
BARBANOJ M
BONAL J
Citation: C. Arroyo et al., DETERMINATION OF CAPTOPRIL IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOR PHARMACOKINETIC STUDIES, Journal of chromatography B. Biomedical sciences and applications, 688(2), 1997, pp. 339-344
Authors:
MASSANA E
BARBANOJ MJ
MOROS C
MORTE A
GICH I
JANE F
Citation: E. Massana et al., NO SEX-RELATED PHARMACOKINETIC AND PHARMACODYNAMIC DIFFERENCES OF CAPTOPRIL, Pharmacological research, 36(1), 1997, pp. 41-47
Citation: L. Falkon et al., IN-VITRO NEUTRALIZING EFFECT OF PROTAMINE SULFATE (PS) ON THE ANTICOAGULANT ACTIVITY OF A NEW LMMH (RO-11, ROVI), Thrombosis and haemostasis, 1997, pp. 383-383
Authors:
GICH I
BAYES M
BARBANOJ MJ
ARTIGAS R
TOST D
MAULEON D
Citation: I. Gich et al., BIOINVERSION OF R(-)-KETOPROFEN AFTER ORAL-ADMINISTRATION IN HEALTHY-VOLUNTEERS, Clinical drug investigation, 11(6), 1996, pp. 347-352
Authors:
BARBANOJ MJ
SALAZAR G
MORTE A
ANTONIJOAN RM
GICH I
JANE F
Citation: Mj. Barbanoj et al., GROUNDS FOR THE INTEGRATION OF PHARMACOKINETIC-PHARMACODYNAMIC DATA, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 43-45
Authors:
SALAZAR G
GICH I
ANTONIJOAN RM
BARBANOJ MJ
JANE F
ARMARIO A
Citation: G. Salazar et al., PHARMACOKINETIC PROFILE OF AN ORAL MODIFIED-RELEASE MORPHINE FORMULATION, IN HEALTHY-YOUNG SUBJECTS OF BOTH SEXES, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 63-63
Authors:
GICH I
MOROS C
BAYES MC
RODRIGUEZ M
BARBANOJ MJ
LOPEZ C
DELGADILLO J
Citation: I. Gich et al., BIOEQUIVALENCE TRIAL BETWEEN ORAL TABLET FORMULATIONS OF CAPTOPRIL, IN HEALTHY-SUBJECTS, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 98-98
Authors:
ALOMAR A
VIDELA S
DELGADILLO J
GICH I
IZQUIERDO I
FORN J
Citation: A. Alomar et al., FLUTRIMAZOLE 1-PERCENT DERMAL CREAM IN THE TREATMENT OF DERMATOMYCOSES - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, COMPARATIVE CLINICAL-TRIAL WITH BIFONAZOLE 1-PERCENT CREAM - EFFICACY OF FLUTRIMAZOLE 1-PERCENTDERMAL CREAM IN DERMATOMYCOSES, Dermatology, 190(4), 1995, pp. 295-300
Authors:
LERMA E
LEE SJ
TUGUES D
OLIVA E
GICH I
PRAT J
Citation: E. Lerma et al., PLOIDY OF 36 STROMAL TUMORS OF THE GASTROINTESTINAL-TRACT - A COMPARATIVE-STUDY WITH FLOW-CYTOMETRY AND IMAGE-ANALYSIS, Analytical and quantitative cytology and histology, 16(6), 1994, pp. 435-440